Phenazine ethosulfate
CAS: 10510-77-7
Rif. 3D-KAA51077
1g | Fuori produzione | ||
10mg | Fuori produzione | ||
25mg | Fuori produzione | ||
50mg | Fuori produzione | ||
100mg | Fuori produzione | ||
250mg | Fuori produzione | ||
500mg | Fuori produzione |
Informazioni sul prodotto
- 5-Ethylphenazin-5-Ium
- 5-Ethylphenazin-5-Ium Ethyl Sulfate
- 5-Ethylphenazine
- 5-Ethylphenazine, ethyl sulfate salt
- 5-Ethylphenazinium ethyl sulfate
- 5-Ethylphenazinium ethyl sulphate
- 5-Ethylphenazinium ethylsulfate
- Ccris 5619
- Ethyl Hydrogen Sulfate
- N-Ethylphenazinium ethyl sulfate
- Vedi altri sinonimi
- N-Ethylphenazonium ethosulfate
- N-Ethylphenazonium ethyl sulfate
- Nsc 402863
- Phenazinium, 5-ethyl-, ethyl sulfate
- Phenazinium, 5-ethyl-, ethyl sulfate (1:1)
- Phenazinium, 5-ethyl-, ethylsulfate
- Sulfuric acid, monoethyl ester, ion(1-), 5-ethylphenazinium
- Phenazine ethosulfate
Phenazine ethosulfate is a phenazine-based drug that has been used in vitrified human blastocysts to study the effects of oxidative stress on embryo development. It is also used in tissue culture, where it inhibits cell growth and stimulates energy metabolism by binding to glutamate receptors. Phenazine ethosulfate has shown antiviral activity against herpes simplex virus type 1 and has been used to treat tissue infections caused by Staphylococcus aureus. Phenazines are activated by reducing agents such as hydrogen peroxide, which leads to the formation of reactive oxygen species (ROS) that exert their toxicity through oxidation reactions with cellular components. Phenazine ethosulfate has an oxidizing potential of +1.5 V vs NHE at pH 7, which makes it a strong oxidant capable of generating ROS.